ClinicalTrials.Veeva

Menu

Fecal Microbiota Transplantation and Newly Diagnosed Ulcerative Colitis (UC) (FinUC)

T

Turku University Hospital (TYKS)

Status

Enrolling

Conditions

Ulcerative Colitis

Treatments

Other: Colored water
Other: Fecal microbiota transplantation

Study type

Interventional

Funder types

Other

Identifiers

NCT04687150
T298/2020

Details and patient eligibility

About

In this FinUC study we are trying to find out the efficacy and safety of the Fecal microbiota transplantation (FMT) in newly diagnosed active ulcerative colitis patients. The study group with newly diagnosed active ulcerative colitis receive an FMT via colonoscopy from a tested general donor, frozen and thawed from a fecal bank at week 0 and at week 4 as an enema at the study nurse´s visit. The control group will be given colored water. The main aim of the FinUC study is to determine how the FMT change of the gut microbiota composition in newly diagnosed active ulcerative colitis patients. The other aim is to determine efficacy and mechanisms of fecal microbiota transplantation.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years
  • Active newly diagnosed colitis (Mayo score <11)
  • Signed informed consent

Exclusion criteria

  • Fulminant severe colitis (Mayo score 11-12 or Truelove and Witts criteria)
  • Gastrointestinal infection
  • Pregnancy
  • Antibiotic therapy at the baseline
  • On-going probiotic medication
  • Unable to provide signed informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

20 participants in 2 patient groups, including a placebo group

The study group
Active Comparator group
Description:
The study group with newly diagnosed active ulcerative colitis receive an FMT via colonoscopy from a tested general donor, frozen and thawed from a fecal bank at week 0 and at week 4 as an enema at the study nurse´s visit
Treatment:
Other: Fecal microbiota transplantation
The control group
Placebo Comparator group
Description:
The control group will be given colored water at same timepoints
Treatment:
Other: Colored water

Trial contacts and locations

1

Loading...

Central trial contact

Kimmo K Salminen, MD, PhD; Jaakko Rautakorpi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems